// App-Quantinova.ai

TPS11614 : TARGET trial: Molecular profiling of circulating tumour DNA to stratify patients to early phase clinical trials.

Researchers

Presenter

  • Matthew Krebs

Principal Investigators

  • Caroline Dive

  • Emma Jane Dean

  • Dominic G Rothwell

  • John Brognard

  • Andrew Wallace

  • Crispin Miller

  • Natalie Cook

  • Saeed Rafii

  • Mahmood Ayub

  • Hui-Sun Leong

  • Carla Siswick

  • Phil Chapman

  • Nigel Smith

  • Allan Jordan

  • Andrew M. Hughes

  • Richard Marais

  • Ged Brady

Medical Centers

  • Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, United Kingdom

  • Cancer Research UK Manchester Institute, Manchester, United Kingdom

  • University of Manchester, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

  • Regional Molecular Genetics Service, St Mary's Hospital, Manchester, United Kingdom

  • Sarah Cannon Research Institute, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Single Center

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved